Canadian Online Pharmacy

CDER New August 15, 2012

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 14, 2012


New and Generic Drug Approvals

August 13, 2012

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Actemra tocilizumab Injectable; Injection Genentech Supplement
An-Sulfur Colloid technetium tc-99m sulfur colloid kit Solution; Injection, Oral Pharmalucence Efficacy Supplement with Clinical Data to Support
Atelvia risedronate sodium Tablet, Delayed Release; Oral Warner Chilcott Llc Labeling Revision
Dexmethylphenidate Hydrochloride dexmethylphenidate hydrochloride Capsule, Extended Release; Oral Mylan Pharms Inc Tentative Approval
Lanoxin digoxin Tablet; Oral Covis Pharma Labeling Revision
Tradjenta linagliptin Tablet; Oral Boehringer Ingelheim Efficacy Supplement with Clinical Data to Support
Zestoretic hydrochlorothiazide; lisinopril Tablet; Oral Astrazeneca Labeling Revision
Zestril lisinopril Tablet; Oral Astrazeneca Labeling Revision

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery